Demin Yu
About
In The Last Decade
Demin Yu
10 papers receiving 403 citations
Peers
Comparison fields: 5 of 78
- Molecular Biology 260
- Cancer Research 93
- Cardiology and Cardiovascular Medicine 63
- Immunology 60
- Pulmonary and Respiratory Medicine 58
Countries citing papers authored by Demin Yu
This map shows the geographic impact of Demin Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demin Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demin Yu more than expected).
Fields of papers citing papers by Demin Yu
This network shows the impact of papers produced by Demin Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Demin Yu. The network helps show where Demin Yu may publish in the future.
Co-authorship network of co-authors of Demin Yu
This figure shows the co-authorship network connecting the top 25 collaborators of Demin Yu. A scholar is included among the top collaborators of Demin Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Demin Yu. Demin Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Circulating MiRNA biomarkers serve as a fingerprint for diabetic atherosclerosis. | 28 |
| 2 | 16 | |
| 3 | 102 | |
| 4 | 1 | |
| 5 | 47 | |
| 6 | 67 | |
| 7 | 127 | |
| 8 | Thrice-daily biphasic insulin aspart 30 may be another therapeutic option for Chinese patients with type 2 diabetes inadequately controlled with oral antidiabetic agents. | 4 |
| 9 | [Analysis of peripheral arterial obstructive disease related factors among diabetic population aged > or = 50]. | 8 |
| 10 | Prevalence and risk factors of peripheral arterial disease in diabetic patients over 50 years old in China. | 11 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.